QNTM
Quantum Biopharma Class B Subordinate Voting Shares
QNTM
QNTM
17 hedge funds and large institutions have $1.91M invested in Quantum Biopharma Class B Subordinate Voting Shares in 2021 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
11% less funds holding
Funds holding: 19 → 17 (-2)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
Holders
17
Holding in Top 10
–
Calls
$812K
Puts
$486K
Top Buyers
| 1 | +$253K | |
| 2 | +$94.9K | |
| 3 | +$41.7K | |
| 4 |
VF
Virtu Financial
New York
|
+$29K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$12.6K |
Top Sellers
| 1 | -$51K | |
| 2 | -$32.9K | |
| 3 | -$31K | |
| 4 |
SPIA
Steward Partners Investment Advisory
New York
|
-$5.73K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$1.13K |